AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company’s mission is to develop and market advanced therapies that address some of the world’s most complex and serious diseases.  AbbVie employs more than 50,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit  www.abbvie.bg.